Your cells use the BCR gene to help control growth signals and the cell’s internal shape. If it does not work normally, especially if part of it joins with the ABL1 gene, blood-forming cells can grow too much and leukemia can develop. In medicine, this gene is important because it is part of the BCR::ABL1 fusion, a key finding in chronic myeloid leukemia and some acute lymphoblastic leukemias. This has made the BCR gene well known in blood cancer testing and treatment.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes provide the instructions for proteins, the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes take place, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
BCRGene function
What if the gene works
The BCR gene helps cells pass signals that guide growth, movement, and shape. It is especially active in the brain and blood cells, where it supports normal cell communication.
Risk
What if the gene does not work
Changes involving the BCR gene, especially BCR::ABL1 fusions, can drive blood cancers, most often chronic myeloid leukemia and sometimes acute lymphoblastic leukemia. Different variants may influence how early disease appears and how severe it is.
Treatment
What does that mean for your treatment
No BCR-specific treatment or drug choice is currently established for pathogenic or loss-of-function variants in the BCR gene itself. In cancer care, the BCR gene is mainly relevant as part of the BCR::ABL1 fusion, which helps guide tyrosine kinase inhibitor use, but that is different from an isolated BCR variant.
Conditions associated with BCR
Gene function
What if the gene works
In everyday cell activity, the BCR gene helps coordinate signals that guide how cells grow, respond, and move. Its protein works as part of the cell’s communication system and helps keep internal signaling organized. This background helps explain what the BCR gene does in blood cells and other tissues during normal function.
The BCR gene helps pass messages from the cell surface to the cell’s control systems. This lets cells respond in an orderly way to routine cues from their surroundings.
Its protein helps manage small signaling switches inside cells. Keeping these switches timed well supports normal cell activity and communication.
Its protein supports the cell’s inner framework, which helps maintain shape and allows controlled movement. This matters when cells need to change position or interact closely with nearby cells.
By linking several signaling proteins, the BCR gene helps messages move efficiently inside the cell. This supports smoother communication during everyday cell tasks.
What is a variant?
A genetic variant is a slight difference in a gene’s DNA sequence. These differences are common and are part of normal human variation, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most clinically important BCR gene variants are rearrangements rather than small DNA spelling changes. In BCR gene variants and leukemia, part of the BCR gene joins with the ABL1 gene to form BCR::ABL1, a fusion that sends constant growth signals and keeps cells dividing when they should pause. Different breakpoints can produce p190, p210, or p230 fusion proteins, which vary in signaling strength. This can influence how strongly the fusion protein drives cell behavior and, in established blood cancers, may shape which features appear and when.
How variants are linked to conditions
Acquired changes involving the BCR gene are most clearly linked to certain blood cancers, especially chronic myeloid leukemia and some cases of acute lymphoblastic leukemia. In BCR gene leukemia associations, the key finding is usually a BCR-ABL1 fusion (two genes joined together) that develops in blood-forming cells during life rather than being inherited. Rarely, other BCR rearrangements are linked to related myeloid cancers.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, however, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't broadly confirmed evidence on specific factors that increase or reduce health risk related to the BCR gene itself. In most cases, BCR becomes important when it is part of an acquired gene change, rather than something clearly shaped by lifestyle or family patterns.
Inheritance of BCR variants
There is not yet a broadly confirmed inherited pattern for a specific BCR-related condition, so how BCR gene variants are inherited depends on the exact change being discussed. The BCR gene is located on chromosome 22, which is an autosome, so each person has one copy from each parent. In the best-known BCR-related blood cancers, the BCR change usually happens during a person’s lifetime rather than being inherited, so it is not typically passed from parent to child.
What does my BCR result mean for my family?
There isn't yet a broadly confirmed inherited pattern tied to a specific condition for BCR. Most well-known BCR changes are acquired during life in blood cells, rather than passed down through families. If you have a specific BCR result and questions about what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the BCR gene usually uses a blood or saliva sample. A lab reads the DNA in the BCR gene, either by checking the whole gene or looking for a known change, and compares it with a reference sequence. Results can show a variant is present, absent, or unclear.
When should I consider getting a genetic test?
Testing related to the BCR gene is usually considered when doctors suspect certain blood cancers, especially chronic myeloid leukemia or some acute leukemias. In this setting, the test looks for a BCR-ABL1 gene fusion in blood or bone marrow, which helps confirm the diagnosis and guide treatment; this change is usually not inherited.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or how strongly the drug acts on its target. This helps explain why the same medication works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It looks at relationships between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. If you want to learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the BCR gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medicine-response decisions, so general medication concerns are best discussed with your doctor. BCR is mainly relevant in certain blood cancers when it joins with ABL1, and that fusion can help doctors choose and monitor treatment.
History
The BCR gene entered medical history through studies of chronic myeloid leukemia and the Philadelphia chromosome, a chromosome change first described in 1960. Researchers later showed that part of the BCR gene becomes joined to the ABL1 gene, creating the BCR-ABL1 fusion that helped explain why this leukemia develops. From these first observations, research expanded steadily. This discovery became a landmark in cancer genetics because it linked a specific gene change to a specific cancer in a clear, testable way. It also helped usher in a new era of targeted cancer treatment, where therapy could be designed around the altered gene signal. Today, the BCR gene remains closely tied to that turning point in modern leukemia research.